Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Colleran currently holds 6,448 shares of Anika Therapeutics, Inc. (ANIK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Colleran has been a net seller of ANIK stock. They have purchased $72.0K and sold $4.5M worth of shares.
David Colleran's most recent insider trade was on Mar 15, 2026, when they sold 6,449 shares at $0.00 per share.
David Colleran serves as Executive at Anika Therapeutics, Inc. (ANIK). They have executed 58 insider transactions totaling $4.6M over their tenure at the company.
David Colleran holds the position of Executive at Anika Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
David Colleran has shown a selling trading pattern, with $72.0K in total purchases and $4.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Colleran was on Mar 1, 2019, when they sold $2.0M worth of PODD shares. This transaction involved 20,975 shares at $94.65 per share.
David Colleran currently owns 6,448 shares of Anika Therapeutics, Inc. (ANIK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Colleran's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Colleran has 58 Form 4 filings on record as an insider at Anika Therapeutics, Inc..
Set alerts for David Colleran and 40,000+ other insiders.